Insiders buy millions of shares of genetic disease research firm.
Insiders continue to be bullish on the pharma and biotech space at current prices. One of the latest buys is inStoke Therapeutics (STOK).
RWT Investments, a partnership that already owns more than 10 percent of shares, picked up 555,556 shares last week, increasing their stake by $10 million.
Then, this week, another big insider trade occurred.
Director Seth Harrison bought 1,388,889 shares via his holding company, Apple Tree Partners IV. This increased his stake to 17.7 million shares and represents a $25 millio...
More